Burns Matteson Capital Management LLC Increases Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Burns Matteson Capital Management LLC lifted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 3.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 757 shares of the biotechnology company’s stock after purchasing an additional 25 shares during the quarter. Burns Matteson Capital Management LLC’s holdings in Axon Enterprise were worth $450,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of the stock. New Wave Wealth Advisors LLC purchased a new position in shares of Axon Enterprise during the 4th quarter worth approximately $40,000. Y.D. More Investments Ltd purchased a new position in Axon Enterprise in the fourth quarter worth $45,000. Prestige Wealth Management Group LLC lifted its holdings in Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 44 shares during the period. GPS Wealth Strategies Group LLC boosted its position in shares of Axon Enterprise by 74.1% during the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock worth $56,000 after purchasing an additional 40 shares in the last quarter. Finally, Versant Capital Management Inc grew its stake in shares of Axon Enterprise by 4,750.0% during the 4th quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company’s stock worth $58,000 after purchasing an additional 95 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Jeffrey C. Kunins sold 21,834 shares of the company’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total value of $12,966,775.92. Following the sale, the insider now owns 154,394 shares of the company’s stock, valued at approximately $91,691,508.72. The trade was a 12.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 50,545 shares of company stock worth $30,721,337 over the last quarter. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $679.24 on Monday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market cap of $51.79 billion, a PE ratio of 175.51, a price-to-earnings-growth ratio of 6.79 and a beta of 1.05. The company has a 50-day simple moving average of $623.43 and a 200-day simple moving average of $496.32. Axon Enterprise, Inc. has a 12 month low of $255.68 and a 12 month high of $698.67.

Analyst Upgrades and Downgrades

AXON has been the topic of a number of research analyst reports. Northland Securities boosted their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. The Goldman Sachs Group boosted their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Robert W. Baird boosted their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, Needham & Company LLC raised their price target on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. One investment analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $542.15.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.